Predictors of attrition during one year of depression treatment

A roadmap to personalized intervention

Diane Warden, A. John Rush, Thomas J. Carmody, T. Michael Kashner, Melanie M. Biggs, M. Lynn Crismon, Madhukar H. Trivedi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

OBJECTIVE: Attrition from treatment in the short and long term for major depressive disorder (MDD) is clearly an adverse outcome. To assist in tailoring the delivery of interventions to specific patients to reduce attrition, this study reports the incidence, timing, and predictors of attrition from outpatient treatment in public mental health clinics. METHODS: Outpatients with psychotic and nonpsychotic MDD receiving measurement-based care in the Texas Medication Algorithm Project (N=179) were evaluated to determine timing and rates of attrition as well as baseline sociodemographic, clinical, and attitu-dinal predictors of attrition. RESULTS: Overall, 23% (42/179) of the patients left treatment by 6 months, and 47% (84/179) left by 12 months. Specific beliefs about the impact of medication, such as its perceived harmfulness, predicted attrition at both 6 and 12 months. Younger age (P=0.0004) and fewer side effects at baseline (P=0.0376) were associated with attrition at 6 months. Younger age (P=0.0013), better perceived physical functioning (P=0.0007), and more negative attitudes about psychiatric medications at baseline (P=0.0075) were associated with attrition at 12 months. CONCLUSIONS: Efforts to elicit attitudes about medications and tailoring educational and other retention interventions for patients with negative beliefs about antidepressants both when initiating a new medication and throughout treatment may reduce attrition. Particular focus on younger patients and those requiring frequent visits may be helpful.

Original languageEnglish (US)
Pages (from-to)113-124
Number of pages12
JournalJournal of Psychiatric Practice
Volume15
Issue number2
DOIs
StatePublished - Mar 2009

Fingerprint

Depression
Major Depressive Disorder
Outpatients
Therapeutics
Antidepressive Agents
Psychiatry
Mental Health
Cohort Studies
Public Health

Keywords

  • Adherence
  • Antidepressant medication
  • Attitudes
  • Attrition
  • Beliefs
  • Compliance
  • Major depressive disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Predictors of attrition during one year of depression treatment : A roadmap to personalized intervention. / Warden, Diane; Rush, A. John; Carmody, Thomas J.; Kashner, T. Michael; Biggs, Melanie M.; Crismon, M. Lynn; Trivedi, Madhukar H.

In: Journal of Psychiatric Practice, Vol. 15, No. 2, 03.2009, p. 113-124.

Research output: Contribution to journalArticle

@article{cc505cab465d4de6a5fc6d1d3ffabeb2,
title = "Predictors of attrition during one year of depression treatment: A roadmap to personalized intervention",
abstract = "OBJECTIVE: Attrition from treatment in the short and long term for major depressive disorder (MDD) is clearly an adverse outcome. To assist in tailoring the delivery of interventions to specific patients to reduce attrition, this study reports the incidence, timing, and predictors of attrition from outpatient treatment in public mental health clinics. METHODS: Outpatients with psychotic and nonpsychotic MDD receiving measurement-based care in the Texas Medication Algorithm Project (N=179) were evaluated to determine timing and rates of attrition as well as baseline sociodemographic, clinical, and attitu-dinal predictors of attrition. RESULTS: Overall, 23{\%} (42/179) of the patients left treatment by 6 months, and 47{\%} (84/179) left by 12 months. Specific beliefs about the impact of medication, such as its perceived harmfulness, predicted attrition at both 6 and 12 months. Younger age (P=0.0004) and fewer side effects at baseline (P=0.0376) were associated with attrition at 6 months. Younger age (P=0.0013), better perceived physical functioning (P=0.0007), and more negative attitudes about psychiatric medications at baseline (P=0.0075) were associated with attrition at 12 months. CONCLUSIONS: Efforts to elicit attitudes about medications and tailoring educational and other retention interventions for patients with negative beliefs about antidepressants both when initiating a new medication and throughout treatment may reduce attrition. Particular focus on younger patients and those requiring frequent visits may be helpful.",
keywords = "Adherence, Antidepressant medication, Attitudes, Attrition, Beliefs, Compliance, Major depressive disorder",
author = "Diane Warden and Rush, {A. John} and Carmody, {Thomas J.} and Kashner, {T. Michael} and Biggs, {Melanie M.} and Crismon, {M. Lynn} and Trivedi, {Madhukar H.}",
year = "2009",
month = "3",
doi = "10.1097/01.pra.0000348364.88676.83",
language = "English (US)",
volume = "15",
pages = "113--124",
journal = "Journal of Psychiatric Practice",
issn = "1527-4160",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Predictors of attrition during one year of depression treatment

T2 - A roadmap to personalized intervention

AU - Warden, Diane

AU - Rush, A. John

AU - Carmody, Thomas J.

AU - Kashner, T. Michael

AU - Biggs, Melanie M.

AU - Crismon, M. Lynn

AU - Trivedi, Madhukar H.

PY - 2009/3

Y1 - 2009/3

N2 - OBJECTIVE: Attrition from treatment in the short and long term for major depressive disorder (MDD) is clearly an adverse outcome. To assist in tailoring the delivery of interventions to specific patients to reduce attrition, this study reports the incidence, timing, and predictors of attrition from outpatient treatment in public mental health clinics. METHODS: Outpatients with psychotic and nonpsychotic MDD receiving measurement-based care in the Texas Medication Algorithm Project (N=179) were evaluated to determine timing and rates of attrition as well as baseline sociodemographic, clinical, and attitu-dinal predictors of attrition. RESULTS: Overall, 23% (42/179) of the patients left treatment by 6 months, and 47% (84/179) left by 12 months. Specific beliefs about the impact of medication, such as its perceived harmfulness, predicted attrition at both 6 and 12 months. Younger age (P=0.0004) and fewer side effects at baseline (P=0.0376) were associated with attrition at 6 months. Younger age (P=0.0013), better perceived physical functioning (P=0.0007), and more negative attitudes about psychiatric medications at baseline (P=0.0075) were associated with attrition at 12 months. CONCLUSIONS: Efforts to elicit attitudes about medications and tailoring educational and other retention interventions for patients with negative beliefs about antidepressants both when initiating a new medication and throughout treatment may reduce attrition. Particular focus on younger patients and those requiring frequent visits may be helpful.

AB - OBJECTIVE: Attrition from treatment in the short and long term for major depressive disorder (MDD) is clearly an adverse outcome. To assist in tailoring the delivery of interventions to specific patients to reduce attrition, this study reports the incidence, timing, and predictors of attrition from outpatient treatment in public mental health clinics. METHODS: Outpatients with psychotic and nonpsychotic MDD receiving measurement-based care in the Texas Medication Algorithm Project (N=179) were evaluated to determine timing and rates of attrition as well as baseline sociodemographic, clinical, and attitu-dinal predictors of attrition. RESULTS: Overall, 23% (42/179) of the patients left treatment by 6 months, and 47% (84/179) left by 12 months. Specific beliefs about the impact of medication, such as its perceived harmfulness, predicted attrition at both 6 and 12 months. Younger age (P=0.0004) and fewer side effects at baseline (P=0.0376) were associated with attrition at 6 months. Younger age (P=0.0013), better perceived physical functioning (P=0.0007), and more negative attitudes about psychiatric medications at baseline (P=0.0075) were associated with attrition at 12 months. CONCLUSIONS: Efforts to elicit attitudes about medications and tailoring educational and other retention interventions for patients with negative beliefs about antidepressants both when initiating a new medication and throughout treatment may reduce attrition. Particular focus on younger patients and those requiring frequent visits may be helpful.

KW - Adherence

KW - Antidepressant medication

KW - Attitudes

KW - Attrition

KW - Beliefs

KW - Compliance

KW - Major depressive disorder

UR - http://www.scopus.com/inward/record.url?scp=67650351152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650351152&partnerID=8YFLogxK

U2 - 10.1097/01.pra.0000348364.88676.83

DO - 10.1097/01.pra.0000348364.88676.83

M3 - Article

VL - 15

SP - 113

EP - 124

JO - Journal of Psychiatric Practice

JF - Journal of Psychiatric Practice

SN - 1527-4160

IS - 2

ER -